Medical Condition News

RSS

Biologists discover vulnerability of brain cancer cells

Biologists at MIT and the Whitehead Institute for Biomedical Research have discovered a vulnerability of brain cancer cells that could be exploited to develop more-effective drugs against brain tumors.

9 Apr 2015

Indoor UV tanning causes skin cancer

The U.S. Surgeon General should declare that indoor ultraviolet radiation tanning causes skin cancer, according to an article published today by the American Journal of Preventive Medicine.

9 Apr 2015

Study finds no strong link between lung cancer risk and reproductive history variables

The Women's Health Initiative Studies, a large prospective study of lung cancer, found no strong associations between lung cancer risk and a wide range of reproductive history variables and only revealed weak support for a role of hormone use in the incidence of lung cancer.

9 Apr 2015

Plymouth researchers receive grant to develop effective therapy for Huntington's disease

Huntington's disease is an hereditary disorder of the nervous system caused by a faulty gene on chromosome four. The faulty gene leads to nerve damage in the area of the brain resulting in gradual physical, mental and emotional changes. Those born to a parent with Huntington's disease have a 50:50 chance of developing it, and there is currently no cure.

9 Apr 2015

Diet rich in high glucoraphanin broccoli reduces blood LDL-cholesterol levels by around 6%

Including a new broccoli variety in the diet reduces blood LDL-cholesterol levels by around 6%, according to the results of human trials led by the Institute of Food Research.

9 Apr 2015

Understanding emotional processing deficit

Kessler Foundation researchers have linked the inability to recognize facial affect (emotion) with white matter damage after traumatic brain injury (TBI), an important first step toward understanding this emotional processing deficit. Their findings indicate a pattern of white matter damage and gray matter atrophy associated with this specific impairment of social cognition after TBI.

9 Apr 2015

AstraZeneca selects Regulus' RG-125 as clinical candidate for treatment of NASH

Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today the selection of RG-125 (AZD4076), a GalNAc-conjugated anti-miR targeting microRNA-103/107 (“miR-103/107”) for the treatment of Non Alcoholic Steatohepatitis (“NASH) in patients with type 2 diabetes/pre-diabetes, as a clinical candidate by AstraZeneca under the companies’ strategic alliance to discover, develop and commercialize microRNA therapeutics.

9 Apr 2015

$Incidence, costs of osteoporotic fractures in China to double by 2035$

Incidence, costs of osteoporotic fractures in China to double by 2035

The results of the first study using a health economics model to project osteoporosis-related fractures and costs for the Chinese population, shows that the country's healthcare system will face a dramatic rise in costs over the next few decades.

8 Apr 2015

Study: Standard nursing assessments may help improve outcomes in cirrhosis patients

Patients hospitalized with advanced cirrhosis, a chronic and degenerative disease of the liver, are at increased risk of death. The tools currently used to assess that risk are limited in predicting which patients will need a liver transplant and which will be healthy enough to survive transplantation.

8 Apr 2015

Changes in height can affect risk of coronary heart disease

The shorter you are- the more your risk of coronary heart disease. That's the key finding of a new study led by the University of Leicester which discovered that every 2.5 inches change in your height affected your risk of coronary heart disease by 13.5%. For example, compared to a 5ft 6inch tall person, a 5 foot tall person on average has a 32% higher risk of coronary heart disease because of their relatively shorter stature.

8 Apr 2015

Prolong Pharmaceuticals' SANGUINATE granted FDA Orphan Drug Designation for SCD treatment

Prolong Pharmaceuticals, LLC, a biopharmaceutical company dedicated to developing products for the treatment of anemias, cancers and their debilitating comorbidities, announced today that the U.S. Food and Drug Administration has granted Orphan Drug Designation for its flagship product SANGUINATE for the treatment of Sickle Cell Disease (SCD).

8 Apr 2015

Study: 9% of U.S. adults have impulsive, angry behavior and have access to guns

An estimated 9 percent of adults in the U.S. have a history of impulsive, angry behavior and have access to guns, according to a study published this month in Behavioral Sciences and the Law. The study also found that an estimated 1.5 percent of adults report impulsive anger and carry firearms outside their homes.

8 Apr 2015

Oral, Head & Neck Cancer Awareness Week: Mount Sinai experts to share tips on cancer prevention

Mouth and throat cancers are the fastest rising cancers today. They account for over 40,000 cases per year in the U.S. The American Cancer Society estimates that there will be 121,790 new cases of head and neck cancer diagnosed in 2015 and 14,240 deaths. These numbers include tongue cancer, throat cancers caused by the human papillomavirus or HPV, voice box cancer, melanoma of the face and thyroid cancers.

8 Apr 2015

Scientists identify brain molecule that triggers schizophrenia-like behaviors, brain changes

Scientists at The Scripps Research Institute have identified a molecule in the brain that triggers schizophrenia-like behaviors, brain changes and global gene expression in an animal model. The research gives scientists new tools for someday preventing or treating psychiatric disorders such as schizophrenia, bipolar disorder and autism.

8 Apr 2015

National MS Society commits $28 million to support new MS research projects, training awards

The National Multiple Sclerosis Society has committed $28 million to support an expected 84 new MS research projects and training awards. These are part of a comprehensive research strategy aimed at stopping MS, restoring function that has been lost, and ending the disease forever – for every single person with MS.

8 Apr 2015

Rhythm, Actavis announce initiation of relamorelin Phase 2b trial for treatment of diabetic gastroparesis

Rhythm, a biopharmaceutical company, and Actavis plc, a leading global pharmaceutical company, announced today the initiation of a Phase 2b clinical trial assessing the efficacy and safety of relamorelin (RM-131), Rhythm's ghrelin agonist, for the treatment of gastroparesis in patients with type 1 and type 2 diabetes.

8 Apr 2015

Uninsured cancer patients may face higher charges for chemotherapy drugs

Uninsured cancer patients are asked to pay anywhere from two to 43 times what Medicare would pay for chemotherapy drugs, according to a new study from the University of North Carolina at Chapel Hill.

8 Apr 2015

Exercise benefits obese, overweight people with NAFLD

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the western world. A new study published in the Journal of Hepatology shows that exercise, regardless of frequency or intensity, benefits obese and overweight adults with NAFLD.

8 Apr 2015

New study analyses physical, psychological consequences of bariatric surgery

Bariatric surgery, or reduction of gastric capacity, is one of the longer lasting options to achieve considerable weight loss in obese people. A Spanish researcher has participated in a study that confirms that the effects of this relatively complex medical surgery are not only physical, but also psychological.

8 Apr 2015

Stroke patients at greater risk of committing suicide compared with other population groups

Stroke patients can be up to twice as likely to commit suicide compared with the rest of the population, and the risk of attempted suicide is highest within the first two years after a stroke. These are the findings of a study from Umeå University published in the journal Neurology.

8 Apr 2015

Medical Condition News

Biologists discover vulnerability of brain cancer cells

Indoor UV tanning causes skin cancer

Study finds no strong link between lung cancer risk and reproductive history variables

Plymouth researchers receive grant to develop effective therapy for Huntington's disease

Diet rich in high glucoraphanin broccoli reduces blood LDL-cholesterol levels by around 6%

Understanding emotional processing deficit

AstraZeneca selects Regulus' RG-125 as clinical candidate for treatment of NASH

Incidence, costs of osteoporotic fractures in China to double by 2035

Study: Standard nursing assessments may help improve outcomes in cirrhosis patients

Changes in height can affect risk of coronary heart disease

Prolong Pharmaceuticals' SANGUINATE granted FDA Orphan Drug Designation for SCD treatment

Study: 9% of U.S. adults have impulsive, angry behavior and have access to guns

Oral, Head & Neck Cancer Awareness Week: Mount Sinai experts to share tips on cancer prevention

Scientists identify brain molecule that triggers schizophrenia-like behaviors, brain changes

National MS Society commits $28 million to support new MS research projects, training awards

Rhythm, Actavis announce initiation of relamorelin Phase 2b trial for treatment of diabetic gastroparesis

Uninsured cancer patients may face higher charges for chemotherapy drugs

Exercise benefits obese, overweight people with NAFLD

New study analyses physical, psychological consequences of bariatric surgery

Stroke patients at greater risk of committing suicide compared with other population groups

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News